脑部放疗,上午比下午敏感许多!
0 [! g. g1 \! b4 Q# v8 n1 X2 ^% A, e
w+ L8 a& D4 K1 S# w( i
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
: L, l/ c0 R' }) m/ h$ x& EGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
9 q; \5 L3 X2 {8 c) ]& V) \$ KRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
4 ]; L1 e9 O0 {, L5 P7 z/ J' ?SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.7 z1 L3 l" E. Q; q Y8 h1 @
2 Q7 _; {! i/ {6 p$ p3 I. v( l( BAbstract; |( f8 `3 W# ~. ]3 N7 J4 g* }- w
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
0 m) h$ k5 q- b2 z: I- k
( W+ B6 Z t* i, ]1 ]4 IMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.5 M7 w8 J& s# T% p
. e+ s; F3 K2 f6 wRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).& p; M3 [% v5 r. U7 E7 ~
4 r0 X! o- N x$ OCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
5 [- E7 b1 F# ^5 C+ S6 C& \# y% Z$ @0 A a N1 H3 U$ t- p1 M
|